BIOMAT Database Logo BIOMAT Database Logo

[The effect of fenazepam and sidnocarb in the phantom pain syndrome]. 1994

E I Danilova, and V N Grafova, and V K Reshetnik

The phantom-pain syndrome model was used to examine the effects of phenazepam, sydnocarb and their combination in chronic oral administration. Phenazepam was shown to have no effects on the development of the phantom-pain syndrome. Sydnocarb arrested the progression of the pain syndrome, reduced its symptoms, alleviated inflammatory manifestations and extremity edema. The agent increased animals' excitability. When their combination was used, the clinical signs of the pain syndrome developed in the same way as with sydnocarb alone. At the same time phenazepam decreased the animals' aggression and excitability caused by sydnocarb. It is suggested that enhancing the efficiency of inhibitory GABAergic processes may result in lower clinical signs of the phantom-pain syndrome in case of involvement of brain catecholaminergic systems whose activation increases the inhibitory functions of its related GABA. The sympathomimetic action of sydnocarb induces an elevation of norepinephrine concentrations in the nerve endings and postsynaptic receptors, resulting in trophic improvement and restoration of tissue viability.

UI MeSH Term Description Entries
D008297 Male Males
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D010591 Phantom Limb Perception of painful and nonpainful phantom sensations that occur following the complete or partial loss of a limb. The majority of individuals with an amputated extremity will experience the impression that the limb is still present, and in many cases, painful. (From Neurol Clin 1998 Nov;16(4):919-36; Brain 1998 Sep;121(Pt 9):1603-30) Pseudomelia,Phantom Limb Pain,Phantom Pain,Phantom Sensation,Limb Pain, Phantom,Limb Pains, Phantom,Limb, Phantom,Limbs, Phantom,Pain, Phantom,Pain, Phantom Limb,Pains, Phantom,Pains, Phantom Limb,Phantom Limb Pains,Phantom Limbs,Phantom Pains,Phantom Sensations,Pseudomelias,Sensation, Phantom,Sensations, Phantom
D011619 Psychotropic Drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). Psychoactive Agent,Psychoactive Agents,Psychoactive Drug,Psychopharmaceutical,Psychopharmaceuticals,Psychotropic Drug,Psychoactive Drugs,Agent, Psychoactive,Agents, Psychoactive,Drug, Psychoactive,Drug, Psychotropic,Drugs, Psychoactive,Drugs, Psychotropic
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds

Related Publications

E I Danilova, and V N Grafova, and V K Reshetnik
[Stereotaxic thalamotomy in the phantom pain syndrome].
January 1980, Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko,
E I Danilova, and V N Grafova, and V K Reshetnik
[Effect of sidnocarb on learning and memory].
October 1987, Biulleten' eksperimental'noi biologii i meditsiny,
E I Danilova, and V N Grafova, and V K Reshetnik
[Pathogenetic mechanisms of phantom-pain syndrome].
January 2015, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
E I Danilova, and V N Grafova, and V K Reshetnik
[Sidnocarb treatment of young schoolchildren with the hyperdynamic syndrome].
January 1988, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
E I Danilova, and V N Grafova, and V K Reshetnik
Phantom sensation, phantom pain, and stump pain.
January 1993, Archives of physical medicine and rehabilitation,
E I Danilova, and V N Grafova, and V K Reshetnik
[The treatment of the phantom pain syndrome with tizanidine].
January 1997, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova,
E I Danilova, and V N Grafova, and V K Reshetnik
[Phantom perception and phantom pain].
February 1992, Fortschritte der Neurologie-Psychiatrie,
E I Danilova, and V N Grafova, and V K Reshetnik
[Phantom limb and phantom pain].
December 1955, Wiener medizinische Wochenschrift (1946),
E I Danilova, and V N Grafova, and V K Reshetnik
The problem of phantom breast and phantom pain.
February 1956, The Journal of nervous and mental disease,
E I Danilova, and V N Grafova, and V K Reshetnik
[Evaluation of the effectiveness of transcutaneous electroneuroanalgesia in phantom pain syndrome].
January 1995, Anesteziologiia i reanimatologiia,
Copied contents to your clipboard!